舒更葡糖 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "舒更葡糖" in Chinese language version.

refsWebsite

Global rank Chinese rank

10nih.gov

4^th place

5^th place

8doi.org

2^nd place

23^rd place

5web.archive.org

1^st place

3archive.org

6^th place

4^th place

2worldcat.org

5^th place

12^th place

1merckconnect.com

low place

1europa.eu

68^th place

209^th place

1adisonline.com

low place

1fda.gov

447^th place

581^st place

adisonline.com

Yang LPH, Keam SJ. PDF. Drugs. 2009, 69 (7): 919–942 [2021-12-14]. PMID 19441874. doi:10.2165/00003495-200969070-00008. （原始内容存档于2011-10-08）.

archive.org

Miller R. Sugammadex: an opportunity to change the practice of anesthesiology?. Anesth Analg. 2007, 104 (3): 477–8. PMID 17312188. doi:10.1213/01.ane.0000255645.64583.e8.
Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology. August 2008, 109 (2): 188–97. PMID 18648227. doi:10.1097/ALN.0b013e31817f5bc7.
Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology.. Anesth Analg. 2007, 104 (3): 575–81. PMID 17312211. doi:10.1213/01.ane.0000244594.63318.fc.

doi.org

Miller R. Sugammadex: an opportunity to change the practice of anesthesiology?. Anesth Analg. 2007, 104 (3): 477–8. PMID 17312188. doi:10.1213/01.ane.0000255645.64583.e8.
Eleveld DJ; Kuizenga, K; Proost, JH; Wierda, JM. A Temporary Decrease in Twitch Response During Reversal of Rocuronium-Induced Muscle Relaxation with a Small Dose of Sugammadex. Anesth Analg. 2008, 104 (3): 582–4. PMID 17312212. doi:10.1213/01.ane.0000250617.79166.7f.
Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology. August 2008, 109 (2): 188–97. PMID 18648227. doi:10.1097/ALN.0b013e31817f5bc7.
Amir (编). Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. Cochrane Database of Systematic Reviews. October 2009, (4): CD007362. PMID 19821409. doi:10.1002/14651858.CD007362.pub2.
Hristovska, Ana-Marija; Duch, Patricia; Allingstrup, Mikkel; Afshari, Arash. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database of Systematic Reviews. 2017-08-14, 8: CD012763. ISSN 1465-1858. PMC 6483345 . PMID 28806470. doi:10.1002/14651858.cd012763.
Brueckmann, B.; Sasaki, N.; Grobara, P.; Li, M. K.; Woo, T.; de Bie, J.; Maktabi, M.; Lee, J.; Kwo, J. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study. British Journal of Anaesthesia. November 2015, 115 (5): 743–751. ISSN 1471-6771. PMID 25935840. doi:10.1093/bja/aev104.
Yang LPH, Keam SJ. PDF. Drugs. 2009, 69 (7): 919–942 [2021-12-14]. PMID 19441874. doi:10.2165/00003495-200969070-00008. （原始内容存档于2011-10-08）.
Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology.. Anesth Analg. 2007, 104 (3): 575–81. PMID 17312211. doi:10.1213/01.ane.0000244594.63318.fc.

europa.eu

ema.europa.eu

Bridion EPAR. European Medicines Agency (EMA). [10 June 2020]. （原始内容存档于2020-06-10）. 引用错误：带有name属性“Bridion EPAR”的<ref>标签用不同内容定义了多次

fda.gov

accessdata.fda.gov

Bridion (sugammadex) Injection. U.S. Food and Drug Administration (FDA). 4 February 2016 [10 June 2020]. （原始内容存档于2020-06-10）.

merckconnect.com

Dosing for BRIDION (sugammadex). www.merckconnect.com. [2019-01-11]. （原始内容存档于2019-01-12）.

nih.gov

ncbi.nlm.nih.gov

Miller R. Sugammadex: an opportunity to change the practice of anesthesiology?. Anesth Analg. 2007, 104 (3): 477–8. PMID 17312188. doi:10.1213/01.ane.0000255645.64583.e8.
Eleveld DJ; Kuizenga, K; Proost, JH; Wierda, JM. A Temporary Decrease in Twitch Response During Reversal of Rocuronium-Induced Muscle Relaxation with a Small Dose of Sugammadex. Anesth Analg. 2008, 104 (3): 582–4. PMID 17312212. doi:10.1213/01.ane.0000250617.79166.7f.
Welliver M. New drug sugammadex; A selective relaxant binding agent. AANA J. 2006, 74 (5): 357–363. PMID 17048555.
Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology. August 2008, 109 (2): 188–97. PMID 18648227. doi:10.1097/ALN.0b013e31817f5bc7.
Amir (编). Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. Cochrane Database of Systematic Reviews. October 2009, (4): CD007362. PMID 19821409. doi:10.1002/14651858.CD007362.pub2.
Hristovska, Ana-Marija; Duch, Patricia; Allingstrup, Mikkel; Afshari, Arash. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database of Systematic Reviews. 2017-08-14, 8: CD012763. ISSN 1465-1858. PMC 6483345 . PMID 28806470. doi:10.1002/14651858.cd012763.
Brueckmann, B.; Sasaki, N.; Grobara, P.; Li, M. K.; Woo, T.; de Bie, J.; Maktabi, M.; Lee, J.; Kwo, J. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study. British Journal of Anaesthesia. November 2015, 115 (5): 743–751. ISSN 1471-6771. PMID 25935840. doi:10.1093/bja/aev104.
Yang LPH, Keam SJ. PDF. Drugs. 2009, 69 (7): 919–942 [2021-12-14]. PMID 19441874. doi:10.2165/00003495-200969070-00008. （原始内容存档于2011-10-08）.
Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology.. Anesth Analg. 2007, 104 (3): 575–81. PMID 17312211. doi:10.1213/01.ane.0000244594.63318.fc.

dailymed.nlm.nih.gov

Bridion- sugammadex injection, solution. DailyMed. 14 December 2018 [10 June 2020]. （原始内容存档于2020-06-10）. 引用错误：带有name属性“Bridion FDA label”的<ref>标签用不同内容定义了多次

web.archive.org

Bridion- sugammadex injection, solution. DailyMed. 14 December 2018 [10 June 2020]. （原始内容存档于2020-06-10）. 引用错误：带有name属性“Bridion FDA label”的<ref>标签用不同内容定义了多次
Dosing for BRIDION (sugammadex). www.merckconnect.com. [2019-01-11]. （原始内容存档于2019-01-12）.
Bridion EPAR. European Medicines Agency (EMA). [10 June 2020]. （原始内容存档于2020-06-10）. 引用错误：带有name属性“Bridion EPAR”的<ref>标签用不同内容定义了多次
Yang LPH, Keam SJ. PDF. Drugs. 2009, 69 (7): 919–942 [2021-12-14]. PMID 19441874. doi:10.2165/00003495-200969070-00008. （原始内容存档于2011-10-08）.
Bridion (sugammadex) Injection. U.S. Food and Drug Administration (FDA). 4 February 2016 [10 June 2020]. （原始内容存档于2020-06-10）.

worldcat.org

Hristovska, Ana-Marija; Duch, Patricia; Allingstrup, Mikkel; Afshari, Arash. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults. Cochrane Database of Systematic Reviews. 2017-08-14, 8: CD012763. ISSN 1465-1858. PMC 6483345 . PMID 28806470. doi:10.1002/14651858.cd012763.
Brueckmann, B.; Sasaki, N.; Grobara, P.; Li, M. K.; Woo, T.; de Bie, J.; Maktabi, M.; Lee, J.; Kwo, J. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study. British Journal of Anaesthesia. November 2015, 115 (5): 743–751. ISSN 1471-6771. PMID 25935840. doi:10.1093/bja/aev104.